| Page 54 | Kisaco Research

Chief IP Counsel U.S., Associate General Counsel & Secretary, Heraeus Medical

" The all-day trade secret program provided an invaluable, in-depth discussion of all aspects of trade secrets that is not available with any other CLE provider."

Global Head of Intellectual Property Platforms, Novartis

" Outstanding event - combination of good substantive content and ample networking opportunities. "

VP, Head of Intellectual Property, Neumora Therapeutics

"Well organized conference with practical, relevant and meaningful panel discussions."

Partner, Quinn Emanuel Urquhart & Sullivan. LLP

"Excellent event with timely content for both in-house practitioners and outside counsel.  Great mix of people engaged in making the conference interesting and worthwhile."

 

David Coleman

Chief Product Officer
iov42 I Interu

David Coleman

Chief Product Officer
iov42 I Interu

David Coleman

Chief Product Officer
iov42 I Interu
 

Anna Roberts

Head of Market Development
iov42 I Interu

Anna Roberts

Head of Market Development
iov42 I Interu

Anna Roberts

Head of Market Development
iov42 I Interu
 

Brennan John

Director, Revenue Cycle
Intermountain Health

Brennan John

Director, Revenue Cycle
Intermountain Health

Brennan John

Director, Revenue Cycle
Intermountain Health